“Post-registration studies on 150 volunteers over the age of 60 have started in the Koltsovo science city in the Novosibirsk region.
This is probably the most important part of the study, as we are doing it with a target audience over 60 who needs this vaccine in the first place, ”he said in an interview at the Science Bar Hopping online festival.
His words are quoted by RIA Novosti.
Maksyutov noted that the study has been launched, 50 volunteers over 60 have already been vaccinated, work in this direction continues.
Earlier in the center "Vector" said that the mass vaccination "EpiVacKorona" will start in 2021.
They noted that the existing equipment will produce up to 5 million doses of the drug annually, but the volume may be increased.
As emphasized in the Kremlin, the process will be phased - taking into account the geography of the country and "the peculiarities of the storage of substances."